Annovis Bio Inc (ANVS)
8.23
-0.52
(-5.94%)
USD |
NYSE |
May 21, 16:00
8.20
-0.03
(-0.36%)
Pre-Market: 07:42
Annovis Bio Cash and Short Term Investments (Quarterly): 3.137M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 3.137M |
| December 31, 2023 | 5.755M |
| September 30, 2023 | 6.355M |
| June 30, 2023 | 15.72M |
| March 31, 2023 | 16.76M |
| December 31, 2022 | 28.38M |
| September 30, 2022 | 31.99M |
| June 30, 2022 | 35.97M |
| March 31, 2022 | 42.67M |
| December 31, 2021 | 45.69M |
| September 30, 2021 | 47.46M |
| Date | Value |
|---|---|
| June 30, 2021 | 49.22M |
| March 31, 2021 | 5.603M |
| December 31, 2020 | 8.075M |
| September 30, 2020 | 8.841M |
| June 30, 2020 | 9.763M |
| March 31, 2020 | 11.12M |
| December 31, 2019 | 0.0019M |
| September 30, 2019 | 0.0563M |
| June 30, 2019 | 0.1046M |
| March 31, 2019 | 0.3366M |
| December 31, 2018 | 0.0353M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
0.0019M
Minimum
Dec 2019
49.22M
Maximum
Jun 2021
18.63M
Average
10.44M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 238.25M |
| Ligand Pharmaceuticals Inc | 310.59M |
| FibroGen Inc | 177.60M |
| SINTX Technologies Inc | 5.762M |
| Stereotaxis Inc | 17.63M |